Borneol in cardio-cerebrovascular diseases: Pharmacological actions, mechanisms, and therapeutics

Songyu Liu,Yu Long,Shuang Yu,Dingkun Zhang,Qiyue Yang,Zhimin Ci,Mingquan Cui,Yulu Zhang,Jinyan Wan,Dan Li,Ai Shi,Nan Li,Ming Yang,Junzhi Lin
DOI: https://doi.org/10.1016/j.phrs.2021.105627
IF: 10.334
2021-07-01
Pharmacological Research
Abstract:<p>With the coming acceleration of global population aging, the incidence rate of cardio-cerebrovascular diseases (CVDs) is increasing. It has become the leading cause of human mortality. As a natural drug, borneol (BO) not only has anti-inflammatory, anti-oxidant, anti-apoptotic, anti-coagulant activities and improves energy metabolism but can also promote drugs to enter the target organs or tissues through various physiological barriers, such as the blood-brain barrier (BBB), mucous membrane, skin. Thus, it has a significant therapeutic effect on various CVDs, which has been confirmed in a large number of studies. However, the pharmacological actions and mechanisms of BO on CVDs have not been fully investigated. Hence, this review summarizes the pharmacological actions and possible mechanisms of BO, which provides novel ideas for the treatment of CVDs.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?